MY184277A - Formulations of deoxyccholic acid and salts thereof - Google Patents
Formulations of deoxyccholic acid and salts thereofInfo
- Publication number
- MY184277A MY184277A MYPI2014000197A MYPI2014000197A MY184277A MY 184277 A MY184277 A MY 184277A MY PI2014000197 A MYPI2014000197 A MY PI2014000197A MY PI2014000197 A MYPI2014000197 A MY PI2014000197A MY 184277 A MY184277 A MY 184277A
- Authority
- MY
- Malaysia
- Prior art keywords
- acid
- deoxyccholic
- formulations
- salts
- composition
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US2011/048806 WO2013028177A1 (en) | 2011-08-23 | 2011-08-23 | Formulations of deoxycholic acid and salts thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY184277A true MY184277A (en) | 2021-03-30 |
Family
ID=45569726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2014000197A MY184277A (en) | 2011-08-23 | 2011-08-23 | Formulations of deoxyccholic acid and salts thereof |
Country Status (18)
| Country | Link |
|---|---|
| JP (1) | JP5919597B2 (ru) |
| KR (5) | KR101919269B1 (ru) |
| CN (3) | CN108619089A (ru) |
| AU (3) | AU2011375432B2 (ru) |
| BR (1) | BR112014000547B1 (ru) |
| CA (1) | CA2842177C (ru) |
| CR (1) | CR20140053A (ru) |
| EA (1) | EA029305B1 (ru) |
| IL (1) | IL230547A (ru) |
| IN (1) | IN2014CN02188A (ru) |
| MX (1) | MX350390B (ru) |
| MY (1) | MY184277A (ru) |
| NZ (1) | NZ620040A (ru) |
| PH (1) | PH12016501175A1 (ru) |
| SG (1) | SG2014013205A (ru) |
| UA (1) | UA113522C2 (ru) |
| WO (1) | WO2013028177A1 (ru) |
| ZA (1) | ZA201401027B (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
| WO2017079700A1 (en) * | 2015-11-04 | 2017-05-11 | Kythera Biopharmaceuticals, Inc. | Treatments of accumulated fat with deoxycholic acid and salts thereof |
| KR101841193B1 (ko) * | 2016-09-22 | 2018-03-22 | 이경락 | 저장성 지방 분해 조성물 및 그의 제조 방법 |
| US20180078621A1 (en) * | 2016-09-22 | 2018-03-22 | Kyoung Lack Lee | Composition for hypotonic lipolysis and manufacturing method thereof |
| KR102051922B1 (ko) * | 2018-04-16 | 2019-12-10 | 주식회사 펜믹스 | 데옥시콜릭산을 포함하는 약학 조성물 |
| KR102172439B1 (ko) * | 2018-12-05 | 2020-10-30 | 송미희 | 지방 분해용 조성물 및 이를 포함하는 주사제 조성물 |
| KR102064864B1 (ko) | 2019-02-08 | 2020-01-10 | (주)제테마 | 국소 주사용 조성물 |
| KR102111346B1 (ko) * | 2019-08-20 | 2020-05-22 | 아영창 | 침전으로부터 안정한 소듐디옥시콜레이트를 포함하는 수용액상 조성물 |
| KR20220026068A (ko) | 2020-08-25 | 2022-03-04 | 강명범 | 지방 분해용 주사제 조성물 |
| CN116617160A (zh) * | 2023-07-25 | 2023-08-22 | 山东则正医药技术有限公司 | 水性混悬液及制备方法、冻干粉及应用、脂肪消减注射剂 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2754709B1 (fr) | 1996-10-23 | 1999-03-05 | Sanofi Sa | Composition cosmetique contenant un antagoniste des recepteurs du neuropeptide gamma et alpha 2 antagonistes susceptibles d'etre incorpores dans une telle composition |
| US6251428B1 (en) * | 1998-07-24 | 2001-06-26 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| US6417179B1 (en) | 1998-10-13 | 2002-07-09 | Craig G. Burkhart | Ear wax solution |
| US20050048126A1 (en) * | 2000-12-22 | 2005-03-03 | Barrett Rabinow | Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug |
| DE10361067A1 (de) * | 2003-12-22 | 2005-07-14 | Aventis Pharma Deutschland Gmbh | Medikamentöse Lipolyse von Fettansammlungen |
| US7754230B2 (en) * | 2004-05-19 | 2010-07-13 | The Regents Of The University Of California | Methods and related compositions for reduction of fat |
| US20060127468A1 (en) | 2004-05-19 | 2006-06-15 | Kolodney Michael S | Methods and related compositions for reduction of fat and skin tightening |
| DK2422789T3 (en) * | 2004-05-19 | 2018-02-26 | Los Angeles Biomedical Res Inst Harbor Ucla Medical Ct | INJECTABLE COMPOSITION CONTAINING SODIUM DEOXYCHOLATE |
| WO2006133160A2 (en) | 2005-06-06 | 2006-12-14 | Georgetown University | Compositions and methods for lipo modeling |
| TW201011755A (en) | 2008-09-10 | 2010-03-16 | Skymedi Corp | Flash memory system and its data recovery method |
| JP5420946B2 (ja) * | 2009-03-23 | 2014-02-19 | 富士フイルム株式会社 | 胆汁酸を含むミノキシジル水性組成物 |
| EP2645099A1 (en) * | 2012-03-30 | 2013-10-02 | Phares Pharmaceutical Research N.V. | Biorelevant compositions |
-
2011
- 2011-08-23 CN CN201810400642.9A patent/CN108619089A/zh active Pending
- 2011-08-23 JP JP2014527128A patent/JP5919597B2/ja active Active
- 2011-08-23 BR BR112014000547-8A patent/BR112014000547B1/pt active IP Right Grant
- 2011-08-23 MX MX2014001495A patent/MX350390B/es active IP Right Grant
- 2011-08-23 KR KR1020177016779A patent/KR101919269B1/ko active IP Right Grant
- 2011-08-23 MY MYPI2014000197A patent/MY184277A/en unknown
- 2011-08-23 AU AU2011375432A patent/AU2011375432B2/en active Active
- 2011-08-23 CN CN201810403291.7A patent/CN108743522A/zh active Pending
- 2011-08-23 CN CN201180072842.2A patent/CN103826608A/zh active Pending
- 2011-08-23 IN IN2188CHN2014 patent/IN2014CN02188A/en unknown
- 2011-08-23 EA EA201490175A patent/EA029305B1/ru unknown
- 2011-08-23 SG SG2014013205A patent/SG2014013205A/en unknown
- 2011-08-23 CA CA2842177A patent/CA2842177C/en active Active
- 2011-08-23 KR KR1020147006855A patent/KR101751585B1/ko active IP Right Review Request
- 2011-08-23 WO PCT/US2011/048806 patent/WO2013028177A1/en active Application Filing
- 2011-08-23 NZ NZ620040A patent/NZ620040A/en not_active IP Right Cessation
- 2011-08-23 KR KR1020187032491A patent/KR102034606B1/ko active IP Right Grant
- 2011-08-23 KR KR1020207002722A patent/KR20200013103A/ko not_active Application Discontinuation
- 2011-08-23 KR KR1020197030233A patent/KR102073536B1/ko active IP Right Grant
- 2011-08-23 UA UAA201400641A patent/UA113522C2/uk unknown
-
2014
- 2014-01-20 IL IL230547A patent/IL230547A/en active IP Right Grant
- 2014-01-30 CR CR20140053A patent/CR20140053A/es unknown
- 2014-02-10 ZA ZA2014/01027A patent/ZA201401027B/en unknown
-
2016
- 2016-04-27 AU AU2016202661A patent/AU2016202661B2/en active Active
- 2016-06-16 PH PH12016501175A patent/PH12016501175A1/en unknown
-
2018
- 2018-04-23 AU AU2018202807A patent/AU2018202807B2/en active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501175A1 (en) | Formulations of deoxycholic acid and salts thereof | |
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| MY160249A (en) | Fatty acid fumarate derivatives and their uses | |
| EA201690287A1 (ru) | 1,4-дизамещенные аналоги пиридазин хинолина и способы лечения состояний, связанных с smn-дефицитом | |
| UA105229C2 (ru) | Фармацевтический состав | |
| AU2018236805B2 (en) | Glutarimide derivatives, use thereof, pharmaceutical composition based thereon and methods for producing glutarimide derivatives | |
| MX348860B (es) | Derivados de pirazoloespirocetona para usarse como inhibidores de acetil-coa carboxilasa. | |
| MX340125B (es) | 2-hidroxi-4-(metiltio) butironitrilo estable en almacenamiento. | |
| PH12015501752B1 (en) | Substituted bisphenyl butanoic phosphonic acid derivatives as nep inhibitors | |
| MX2018001145A (es) | Métodos para la preparación de ácidos biliares y derivados de los mismos. | |
| PH12015502802A1 (en) | Formulation comprising a hypolipidemic agent | |
| MX2016008665A (es) | Derivado basado en 1,2-naftoquinona y metodo de preparacion del mismo. | |
| MX2013010046A (es) | Administracion parenteral de tapentadol. | |
| MY171414A (en) | Compositions and methods for improving the compatibility of water soluble herbicide salts | |
| MX2009007265A (es) | Sales, composiciones liquidas acuosas que cotienen sales de acido s-(+)-abscisico y metodos para su preparacion. | |
| CY1115372T1 (el) | Συνθεσεις δεσοξυχολικου οξεος και αλατα αυτου | |
| CA2922375C (en) | Alpha-tea salt forms: compositions and uses for treating disease | |
| EA201890018A1 (ru) | Композиция для придания формы волосам | |
| PH12017500435A1 (en) | A salt of cephalosporin derivative, its crystalline solid and a method of manufacturing thereof | |
| MX2015010434A (es) | Derivados de acido bisfenil-butanoico sustituido como inhibidores de la endopeptidasa neutra (nep), con una mayor eficacia in vivo. | |
| PH12018501046A1 (en) | Crystals of monovalent cation salt of 3-hydroxyisovaleric acid, and method for producing said crystals | |
| EA201992511A1 (ru) | Составы дезоксихолевой кислоты и ее солей | |
| EA201790055A3 (ru) | Составы дезоксихолевой кислоты и ее солей | |
| FR2975992B1 (fr) | Procede de preparation d'un compose fluoromethylpyrazole sous forme acide carboxylique ou derivee | |
| MX2014012466A (es) | Composiciones acuosas que contienen la sal de potasio del acido (s)-(+)-abscisico. |